Search company, investor...

Predict your next investment

Bd Biosciences company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
bdbiosciences.com

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

Partners & Customers

10

About Bd Biosciences

Bd Biosciences is a medical device company. It had developed the Bd Multitest 6-color Tbnk Reagent, Model 644611.BD Biosciences is a world leader in bringing innovative diagnostic and research tools to life scientists, clinical researchers, laboratory professionals, and clinicians who are involved in basic research, drug discovery and development, biopharmaceutical production, and disease management.

Headquarters Location

2350 Qume Dr.

San Jose, California, 95131,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Bd Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Bd Biosciences in 2 Expert Collections, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Bd Biosciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Bd Biosciences Rank

Latest Bd Biosciences News

Global Cell And Tissue Culture Supplies Market Size To Exceed 58.3 billion by 2030

Dec 1, 2022

GlobeNewswire The Global Cell and Tissue Culture Supplies Market Size was valued at USD 21.9 billion in 2021 and the worldwide cell and tissue culture supplies market is expected to reach USD 58.3 billion by 2030, according to a research report published by Spherical Insights & Consulting. Companies Covered: Avantor, Inc., BD Biosciences, BioIVT, Cell Culture Technologies, Corning Inc., GE Healthcare Life Sciences, Irvine Scientific Inc., Lonza Group AG, Merck Millipore GmbH, MP Biomedicals LLC, ORIGIO a/s, PromoCell GmbH, Sigma-Aldrich Corporation, Thermo Fischer Scientific Inc., Vitrolife AB, and others 20+ prominent key players we have added in the final report. Global Economy: Recession Risk Rising Analysis and Russia-Ukraine Conflict War Impact we have added in the final premium report. AD AD New York, United States , Nov. 30, 2022 (GLOBE NEWSWIRE) -- The Global Cell And Tissue Culture Supplies Market Size to grow from USD 21.9 billion in 2021 to USD 58.3 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period. The cell and tissue culture supplies market has grown due to the demand for artificial organs and biopharmaceuticals. In addition, R&D activities are increasing along with the use of cell and tissue cultures. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/1330 The Incubators segment to account for the largest market size during the forecast period Based on the instruments, the global cell and tissue culture supplies market are categorized into Biosafety Cabinets, Cryostorage Equipment, Incubators, And Pipetting Instruments. The Incubators segment to account for the largest market size during the forecast period. Incubators are frequently used to investigate tissue cultures, which entail the removal of small pieces of animal or plant tissue. The Petri dishes segment to hold a higher CAGR during the forecast period Based on the type, the Cell and tissue culture supplies market are categorized into Petri Dishes, Roller Bottle Culture Apparatus, Culture Systems & Bioreactors, Culture Cylinders, Spreaders, Syringe Fillers, Serological Pipettes, Scrapers & Lifters, And Tissue Grinders. The Petri dishes segment to hold a higher CAGR during the forecast period. In laboratories, Petri dishes are frequently used to research microorganisms. It is a shallow cylindrical round glass that is essential for cultivating cultures of cells, viruses, bacteria, and other microbes. These dishes can also be used for other things, such as drying off liquids to remove residue. Browse 79 market data Tables and 70 Figures spread through 195 Pages and in-depth TOC on Global Cell And Tissue Culture Supplies Market Size , Share, and COVID-19 Impact Analysis, By Instruments (Biosafety Cabinets, Cryostorage Equipment, Incubators, And Pipetting Instruments), By Type (Petri Dishes, Roller Bottle Culture Apparatus, Culture Systems & Bioreactors, Culture Cylinders, Spreaders, Syringe Fillers, Serological Pipettes, Scrapers & Lifters, And Tissue Grinders), By Consumable (Sera, Contamination Detection Kits, Reagents, Media, And Cryoprotective Agents), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 2030. AD Buy Now Full Report: https://www.sphericalinsights.com/checkout/1330 On credit portfolios, the COVID-19 epidemic has had a negative effect. The enormous growth has hampered the solvency of customers and businesses in unemployment and interruption of economic activity. Central banks have adopted a proactive strategy of injecting money into the market by decreasing interest rates and implementing asset purchase programmes. With persistent geopolitical tensions, global trade battles, and sporadic hurricanes and earthquakes, managing and monitoring credit, market, liquidity, and operational risk across financial markets was challenging enough. Chief risk officers and their teams have had to reevaluate outdated methods and assumptions used to manage and monitor risk due to the present pandemic crisis. The global repercussions of COVID-19 have demonstrated the significance of interconnection in international cooperation. As a result, many governments have been hurrying to find, assess, and buy trustworthy AI-powered solutions. The Media segment is to hold a higher CAGR during the forecast period. Based on the consumables, the Cell and tissue culture supplies market are categorized into Sera, Contamination Detection Kits, Reagents, Media, And Cryoprotective Agents. The Media segment is to hold a higher CAGR during the forecast period. Certain inorganic chemicals and inorganic salts make up the chemical or synthetic medium that is used in tissue culture. The growth of the culture medium may also contain several types of tissue cultures and living cells. Two types of media are referred to as special-purpose media: selective media and enriched media. Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/1330 Asia-Pacific to hold a higher CAGR during the forecast period. The Global Cell and Tissue Culture Supplies Market has been segmented into five major regions: North America, Europe, Asia-Pacific, South America, The Middle East and Africa. North America is estimated to account for the highest market share in 2022. This is primarily due to the emergence of significant market participants and the rising desire for individualized treatment. Additionally, the US government supports medical research because healthcare is one of the nation's top objectives. The Human Cancer Models Initiative, unveiled in 2016, has a three-year goal of developing 1,000 novel cell lines for researchers to analyze. AD Some of the Key Developments: In June 2022, to improve efficiency and productivity in bioprocesses for manufacturing monoclonal antibodies, vaccines, viral vectors, and therapeutic cells, Evonik introduced the cQrex range of cell culture components. In February 2022, Cellular Evolution raised GBP 1.75 million to hasten the introduction of their continuous cell culture technology. Get Discount At @ https://www.sphericalinsights.com/request-discount/1330 Key Companies & Recent Developments: The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the Global Cell and Tissue Culture Supplies Market include Avantor, Inc., BD Biosciences, BioIVT, Cell Culture Technologies, Corning Inc., GE Healthcare Life Sciences, Irvine Scientific Inc., Lonza Group AG, Merck Millipore GmbH, MP Biomedicals LLC, ORIGIO a/s, PromoCell GmbH, Sigma-Aldrich Corporation, Thermo Fischer Scientific Inc., and Vitrolife AB. And Others. Browse Related Reports: Global Life Science Reagent Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Cell and Tissue Culture Reagents, Chromatography Reagents, Clinical Chemistry Reagents, Immunoassay Reagents, Molecular Diagnostic Reagents, Microbiology Reagents, and Other Product Types), By End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and Other End Users),and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 2030. Global Viral Vector And Plasmid DNA Testing Services Market Size, Share, and COVID-19 Impact Analysis, By Testing Services (Safety, Genetic Characterization, Purity, Identity, and Potency), By End-User (Research Organizations and Pharmaceutical and Biotechnological Companies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 2030. AD

Bd Biosciences Investments

1 Investments

Bd Biosciences has made 1 investments. Their latest investment was in Adaptive Biotechnologies as part of their Series F on May 5, 2015.

CBI Logo

Bd Biosciences Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/6/2015

Series F

Adaptive Biotechnologies

$195M

Yes

11

Date

5/6/2015

Round

Series F

Company

Adaptive Biotechnologies

Amount

$195M

New?

Yes

Co-Investors

Sources

11

Bd Biosciences Portfolio Exits

1 Portfolio Exit

Bd Biosciences has 1 portfolio exit. Their latest portfolio exit was Adaptive Biotechnologies on June 27, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/27/2019

IPO

$99M

Public

13

Date

6/27/2019

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

13

Bd Biosciences Acquisitions

1 Acquisition

Bd Biosciences acquired 1 company. Their latest acquisition was FlowJo on January 01, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/1/2017

$99M

Acquired

1

Date

1/1/2017

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired

Sources

1

Bd Biosciences Partners & Customers

10 Partners and customers

Bd Biosciences has 10 strategic partners and customers. Bd Biosciences recently partnered with Torrey View on November 11, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

11/22/2021

Vendor

United States

06:50 ET BD Selects Torrey View by Breakthrough as San Diego Campus for Growing Biosciences Business

Torrey View is a 10-acre , world-class life sciences research and development campus that Breakthrough Properties is creating alongside its co-equity partner Mitsui Fudosan America .

1

10/9/2020

Partner

China

3/26/2020

Partner

Germany, France, Japan, United States, United Kingdom, and Switzerland

Novartis and Life Sciences Companies Commit Expertise and Assets to the Fight Against COVID-19 Pandemic alongside Bill & Melinda Gates Foundation

Basel , March 26 , 2020 -- Today , Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development , manufacture and delivery of vaccines , diagnostics , and treatments for COVID-19 in response to the pandemic .

5

6/13/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

9/5/2013

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

11/22/2021

10/9/2020

3/26/2020

6/13/2017

9/5/2013

Type

Vendor

Partner

Partner

Partner

Partner

Business Partner

Country

United States

China

Germany, France, Japan, United States, United Kingdom, and Switzerland

United States

United States

News Snippet

06:50 ET BD Selects Torrey View by Breakthrough as San Diego Campus for Growing Biosciences Business

Torrey View is a 10-acre , world-class life sciences research and development campus that Breakthrough Properties is creating alongside its co-equity partner Mitsui Fudosan America .

Novartis and Life Sciences Companies Commit Expertise and Assets to the Fight Against COVID-19 Pandemic alongside Bill & Melinda Gates Foundation

Basel , March 26 , 2020 -- Today , Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development , manufacture and delivery of vaccines , diagnostics , and treatments for COVID-19 in response to the pandemic .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

5

10

10

Compare Bd Biosciences to Competitors

A
AnchorDx

AnchorDx is a precision medicine company engaged in the clinical research & development of targeted DNA methylation high-throughput sequencing solutions for the early diagnosis of cancer.

Deep Lens Logo
Deep Lens

Deep Lens is an AI company focused on identifying patients for clinical trials using VIPER, an AI-driven, digital pathology cloud platform which for over ten years has allowed pathology groups to collaborate on groundbreaking cancer research across dozens of cancer types.

Atropos Health Logo
Atropos Health

Atropos Health is a developer of a physician consultation service powered by research-grade, real-world data. Using millions of anonymized patient records, the company helps providers answer clinical questions that have fallen through the cracks of the evidence-based literature. Atropos empowers more robust research and effective care delivery by leveraging insights from free-text notes and other non-standard data entries that often go overlooked. The company was founded in 2019 and is based in New York, New York.

Helix Logo
Helix

Helix connects people with the most fundamental aspect of what makes them unique: their own DNA. The company empowers consumers to discover and explore their own genomes through insights provided by its ecosystem of content partners.

Syapse Logo
Syapse

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations. The company was formerly known as BDLicense. Syapse was founded in 2008 and is based in San Francisco, California.

Holmusk Logo
Holmusk

Holmusk is a data science and digital therapeutics company with a global presence that is dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Holmusk's proprietary technology powers data-driven medicine that leverages analytic and digital tools to address the unmet need in healthcare and pharma-life science.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.